Title: ARL9 is Upregulated and Serves as a Biomarker for a Poor Prognosis in Colon
Adenocarcinoma
Version: 1 Date: 12 Dec 2022
Reviewer's report:
The present paper is a very interesting and exciting study. The manuscript is well written and
structured. The analyses and images of the research are appropriate, and the methodology is
adequate for the topic. The results documentation well supports the points of discussion as well
as the modest conclusions. It would be suitable for publication.
Title: ARL9 is Upregulated and Serves as a Biomarker for a Poor Prognosis in Colon
Adenocarcinoma
Version: 1 Date: 12 Dec 2022
Reviewer's report:
The present paper is a very interesting and exciting study. The manuscript is well written and
structured. The analyses and images of the research are appropriate, and the methodology is
adequate for the topic. The results documentation well supports the points of discussion as well
as the modest conclusions. It would be suitable for publication.
Please review this paper.
user
Title: ARL9 is Upregulated and Serves as a Biomarker for a Poor Prognosis in Colon
Adenocarcinoma
Version: 1 Date: 12 Dec 2022
Reviewer's report:
The present paper is a very interesting and exciting study. The manuscript is well written and
structured. The analyses and images of the research are appropriate, and the methodology is
adequate for the topic. The results documentation well supports the points of discussion as well
as the modest conclusions. It would be suitable for publication.
assistant